Page 21 - IMR ANNUAL REPORT 2021: INSTITUTE FOR MEDICAL RESEARCH
P. 21
8 IMR ANNUAL REPORT 2021
Paraneoplastic Neurological Syndrome (PNS) anti-
9 518 660
bodies
Skin Antibodies: Anti-BP 180, Anti-BP 230: Anti-Des-
78
10 moglein-1 & Anti-Desmoglein-3 334 203
ALLERGY AND IMMUNOLOGY RESEARCH CENTRE (AIRC) 12 *Anti-Cardiolipin Antibodies (IgM & IgG) 2756 1233
696
Specific Liver Antibodies Panel (SLA)
11
1378
*Anti-Cyclic Citrullinated Antibody (CCP)
13
1925
*Tissue antibody
b) Anti-Mitochondrial Antibodies (AMA)
14 a) Anti-Smooth Muscle Antibodies (ASMA) 3542 2540
c) Anti-Liver Kidney Microsomal Antibodies (LKM)
d) Anti-Gastric Parietal Cell Antibodies (APC)
15 *Extractable nuclear antigen (ENA) 3522 2777
16 *Anti –β2-Glycoprotein antibodies (IgG & IgM) 1239 1307
*Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
a) C-ANCA
17 2244 1664
b) P-ANCA
* Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
a) Anti - myeloperoxidase (MPO)
18 2244 1664
b) Anti-Proteinase 3 (PR3)
TOTAL 21912 18739
(*) Tests were handed over to MOH hospitals in October 2021
Primary Immunodeficiency Unit
The Primary Immunodeficiency (PID) unit offers two immunologic screening tests;
namely the Lymphocyte Subset (TBNK) Enumeration Test and Immunoglobulin
and Complement Quantitation. The unit also offers specific functional assays;
Dihydrorhodamine (DHR) test for the chronic granulomatous disease, Bruton’s
tyrosine kinase (BTK) by flow cytometry for X-linked agammaglobulinemia and
lymphocyte proliferation assay for assessment of immune function in selective
cases suspected with T cells defects. The workload for 2021 is shown in the
following table.
) Unit W
or
c
y (P
ID
a
d in 2
0
klo
21
r
P
Primary Immunodeficiency (PID) Unit Workload in 2021
odeficien
y Immun
imar
No. Name of tests Tests performed
1 Lymphocyte Subset (TBNK) Enumeration Test 1637
2 Immunoglobulin A 2080
3 Immunoglobulin G 2219
4 Immunoglobulin M 2007
5 Complement C3 2092
6 Complement C4 2092
7 Dihydrorhodamine (DHR) test 158